Literature DB >> 6648599

Prevalence and causes of vision loss in southern Sudan.

T Tizazu, F M Mburu.   

Abstract

Blindness in Southern Sudan is thought to be highly prevalent due to the high prevalence of onchocerciasis and trachoma. In addition, socioeconomic development in the area has been low and growth slow. Communities in the South have not changed much having been unaffected by modern institutions more prevalent in the North. Traditional methods of farming, fishing and pastoralism still persist. However, even these may be hampered by the large scale presence of blackfly and trachoma. This paper describes one approach to define the prevalence and causes of vision loss in Southern Sudan.

Entities:  

Mesh:

Year:  1983        PMID: 6648599     DOI: 10.1016/0277-9536(83)90392-1

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  Prevalence of eye diseases in primary school children in a rural area of Tanzania.

Authors:  S H Wedner; D A Ross; R Balira; L Kaji; A Foster
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

Review 2.  Blindness in Africa: present situation and future needs.

Authors:  S Lewallen; P Courtright
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

3.  Primary eye care in rural sub-Saharan Africa.

Authors:  P G Steinkuller
Journal:  Int Ophthalmol       Date:  1987-12       Impact factor: 2.031

4.  Prevalence and causes of blindness in the northern Transvaal.

Authors:  P J Bucher; C B Ijsselmuiden
Journal:  Br J Ophthalmol       Date:  1988-10       Impact factor: 4.638

5.  Blindness and visual impairment in southern Malawi.

Authors:  M C Chirambo; J M Tielsch; K P West; J Katz; T Tizazu; L Schwab; G Johnson; J Swartwood; H R Taylor; A Sommer
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

6.  Prevalence and causes of blindness and low vision in southern Sudan.

Authors:  Jeremiah Ngondi; Francis Ole-Sempele; Alice Onsarigo; Ibrahim Matende; Samson Baba; Mark Reacher; Fiona Matthews; Carol Brayne; Paul M Emerson
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.